The new, stringent MDR and IVDR regulations: Viewing this change as an opportunity

Abstract

The healthcare and life science sector is growing inexorably, and is now a multi-billion dollar industry. In 2016 the companies in this sector posted sales of USD 140 billion, and their profitability more than doubled by comparison with 2010. The pharmaceutical, diagnostics, medtech and chemical sectors have become Switzerland’s most powerful export industry, and significant number of approved medications and diagnostics contain biotech elements.